{"id":5925,"date":"2013-04-05T13:54:09","date_gmt":"2013-04-05T17:54:09","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=5925"},"modified":"2013-04-05T13:54:25","modified_gmt":"2013-04-05T17:54:25","slug":"cel-sci-corporation-nyseamexcvms-investigation-on-multikine","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925","title":{"rendered":"CEL-SCI Corporation (NYSEAMEX:CVM)&#8217;s investigation on Multikine"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; CEL-SCI Corporation (NYSEAMEX:CVM)\u00a0is a global leader in the research and development of cancer treatment and drugs, by utilizing the immune system of the body. The company is presently involved in a pioneering investigation therapy called Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Additionally, the company is involved in several immunological projects. The latest stress is on the immunization as a possible treatment for H1N1 hospitalized patients- a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its groundbreaking LEAPS technology platform.<\/p>\n<p style=\"text-align: justify;\">The aggregate market value of the voting stock held by non-affiliates of the CVM is based on the closing sales price of the common stocks on March 31, 2012, which was $120,199,660. Currently trading at $0.278, up by 0.51%. Yesterday, its stock value reached as high as $0.28 and dipped at $0.2426. Considering the quoted rates of the previous day, the market share price gained 10.26% yesterday, with a significant volume rise in the trading. A study of last three months trading revealed that on an average around 1.2 million shares of CEL-CSI were traded on NASDAQ. A further study of the year long trading reveals, that the value of the stocks reached an all time high of $0.58 and the lowest quoted rate was $0.205. With a market capitalization of around $85 million, the company has made a singular presence of trading on the stock exchange.<\/p>\n<p style=\"text-align: justify;\">With revolutionizing technology in new age immunological studies, with a view to resolve the long craving demands of Medical Science, CEL-SCI is all set to draw its own horizon in the global markets. Its current presence on the NASDAQ is a robust indication of its ambitions and organizational growth. The principal traders of the NASDAQ have shown a considerable interest in this company. Subsequently, investing in CVM stocks will be a brilliant choice for investors who have a vision of the future. The rest is for the investors to find out in the coming times.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; CEL-SCI Corporation (NYSEAMEX:CVM)\u00a0is a global leader in the research and development of cancer treatment and drugs, by utilizing the immune [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[263],"tags":[1947,1948],"stock_ticker":[],"class_list":["post-5925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-cel-sci-corporation-nyseamexcvm","tag-nyseamexcvm","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CEL-SCI Corporation (NYSEAMEX:CVM)&#039;s investigation on Multikine - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CEL-SCI Corporation (NYSEAMEX:CVM)&#039;s investigation on Multikine - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; CEL-SCI Corporation (NYSEAMEX:CVM)\u00a0is a global leader in the research and development of cancer treatment and drugs, by utilizing the immune [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-04-05T17:54:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-04-05T17:54:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"CEL-SCI Corporation (NYSEAMEX:CVM)&#8217;s investigation on Multikine\",\"datePublished\":\"2013-04-05T17:54:09+00:00\",\"dateModified\":\"2013-04-05T17:54:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\"},\"wordCount\":335,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg\",\"keywords\":[\"CEL-SCI Corporation (NYSEAMEX:CVM)\",\"NYSEAMEX:CVM\"],\"articleSection\":[\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\",\"name\":\"CEL-SCI Corporation (NYSEAMEX:CVM)'s investigation on Multikine - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg\",\"datePublished\":\"2013-04-05T17:54:09+00:00\",\"dateModified\":\"2013-04-05T17:54:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CEL-SCI Corporation (NYSEAMEX:CVM)&#8217;s investigation on Multikine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CEL-SCI Corporation (NYSEAMEX:CVM)'s investigation on Multikine - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925","og_locale":"en_US","og_type":"article","og_title":"CEL-SCI Corporation (NYSEAMEX:CVM)'s investigation on Multikine - Wall Street PR","og_description":"Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; CEL-SCI Corporation (NYSEAMEX:CVM)\u00a0is a global leader in the research and development of cancer treatment and drugs, by utilizing the immune [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-04-05T17:54:09+00:00","article_modified_time":"2013-04-05T17:54:25+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"CEL-SCI Corporation (NYSEAMEX:CVM)&#8217;s investigation on Multikine","datePublished":"2013-04-05T17:54:09+00:00","dateModified":"2013-04-05T17:54:25+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925"},"wordCount":335,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg","keywords":["CEL-SCI Corporation (NYSEAMEX:CVM)","NYSEAMEX:CVM"],"articleSection":["Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925","url":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925","name":"CEL-SCI Corporation (NYSEAMEX:CVM)'s investigation on Multikine - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg","datePublished":"2013-04-05T17:54:09+00:00","dateModified":"2013-04-05T17:54:25+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/090126_0821.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cel-sci-corporation-nyseamexcvms-investigation-on-multikine-5925#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"CEL-SCI Corporation (NYSEAMEX:CVM)&#8217;s investigation on Multikine"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/5925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=5925"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/5925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/5926"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=5925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=5925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=5925"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=5925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}